Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Therapeutic strategies aimed at modulating the immune system by inducing regulatory T cells (Tregs) and promoting the production of blocking antibodies (IgG4) against specific grass pollen allergens. This approach seeks to restore immune tolerance and alleviate allergic inflammation associated with grass pollen allergies.
Induction of regulatory T cells (Tregs) and blocking antibody (IgG4) production to suppress IgE-mediated allergic responses to grass pollen allergens.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune System Modulation via Induction of Regulatory T Cells and Blocking Antibody Production Against Specific Grass Pollens (Treg Induction/Blocking Antibody Production).